Menu Patients About Contact Your patients deserve better than the status quo. Tablo is an enterprise solution delivering acute and chronic dialysis, from bedside dialysis in the ICU to the living room. Renal Replacement Therapy in Hospitals Tablo can substantially reduce supply costs and improve labor productivity, freeing you from infrastructure requirements so you can easily dialyze at a patient’s bedside, in the ICU, or in the dialysis unit.3 Read our case study: Cost savings in the Cleveland Clinic ICU Chronic Care in Dialysis Clinics Tablo can reduce infrastructure costs and expand the potential locations and configurations of a dialysis clinic, all while creating a meaningfully better experience for patients. Watch video: Empowering dialysis patients with in-center self-care Home Dialysis Tablo’s user friendly interface, quick training, simple setup, and sensor-based automation make home hemodialysis an easy, efficient, and flexible option for chronic dialysis patients. Review our home clinical trial results: Safety and efficacy of the Tablo hemodialysis system for in-center and home hemodialysis View clinical evidence With just tap water and a power outlet, Tablo is ready to go. All-in-one dialysis system Tablo is an enterprise solution that saves time and money.2 Its fully integrated water purification system produces dialysate that’s customized to the patient’s prescription. No more hauling portable reverse osmosis machines or bags to the bedside, managing a water treatment room for dialysis, or batching dialysate. Easy to learn, easy to use With Tablo’s intuitive touchscreen guidance and animated instructions, you can train new users in hours, not weeks. Sensors and advanced software help automate much of the setup, treatment management and maintenance. Step-by-step alarm resolution means no more flipping through manuals. Tablo offers multiple user levels so dialysis experts can fully manage and customize patient care in a flexible, streamlined way while non-specialized HCPs and self-care patients can rely on guided instructions. Connected and intelligent Treatment data and disinfection reports are stored in the Tablo Cloud, accessible from wherever you are or integrated with your EMR. With two-way wireless data transfer, remote monitoring and reporting, Tablo can provide insights and diagnostics that improve program efficiency and minimize downtime. Spend time on value-added care, not on training, troubleshooting, or reporting. Read more Optimizing Kidney Replacement in Critical Care: SLED Can Play a Bigger Role in the ICU PDF Request a demo Have a question? Want to see Tablo in action? Leave us your info and we’ll be in touch! Important note regarding supply for in-home use: Tablo will begin rollout in select sites over the coming months to ensure the highest level of training and support for Tablo home patients. Get in touch now to be a part of our expansion. By submitting this contact form, you are agreeing to the terms of our privacy policy. We value your information security and protect your privacy. Patients, please use this form. First Name * Last Name * Email Address * Business Phone Zip or Postal Code * State or Province * Please Select… Alaska Alabama Arkansas American Samoa Arizona California Colorado Connecticut D.C. Delaware Florida Micronesia Georgia Guam Hawaii Iowa Idaho Illinois Indiana Kansas Kentucky Louisiana Massachusetts Maryland Maine Marshall Islands Michigan Minnesota Missouri Marianas Mississippi Montana North Carolina North Dakota Nebraska New Hampshire New Jersey New Mexico Nevada New York Ohio Oklahoma Oregon Pennsylvania Puerto Rico Palau Rhode Island South Carolina South Dakota Tennessee Texas Utah Virginia Virgin Islands Vermont Washington Wisconsin West Virginia Wyoming Military Americas Military Europe/ME/Canada Military Pacific Alberta Manitoba British Columbia New Brunswick Newfoundland and Labrador Nova Scotia Northwest Territories Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon Territory Other Country * Please select United States United Kingdom Canada India Netherlands Australia South Africa France Germany Singapore Sweden Brazil Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brit/Indian Ocean Terr. Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Dem. Republic Of Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland French Guiana French Polynesia French Southern Terr. Gabon Gambia Georgia Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard/McDonald Isls. Honduras Hong Kong Hungary Iceland Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea (North) Korea (South) Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montserrat Morocco Mozambique Myanmar N. Mariana Isls. Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Samoa San Marino Sao Tome/Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Slovak Republic Slovenia Solomon Islands Somalia Spain Sri Lanka St. Helena St. Pierre and Miquelon St. Vincent and Grenadines Sudan Suriname Svalbard/Jan Mayen Isls. Swaziland Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks/Caicos Isls. Tuvalu Uganda Ukraine United Arab Emirates US Minor Outlying Is. Uruguay Uzbekistan Vanuatu Vatican City Venezuela Viet Nam Virgin Islands (British) Virgin Islands (U.S.) Wallis/Futuna Isls. Western Sahara Yemen Zambia Zimbabwe Institution * Job Role * Please Select… Administrator Biomedical Staff Dialysis Nurse Dialysis Technician ICU Nurse Nephrologist Nurse Manager Other – Nurse Other – Physician Other How can we help? Please Select… I would like a demo I have questions, please contact me Please send me brochures Where are you interested in using Tablo? Please Select… Home In-Center ICU Acute (Dialysis Unit) Frequently Asked Questions What are the advantages of Tablo for my facility? In the acute setting, Tablo is proven to reduce costs and simplify your dialysis program. Its mobility and integrated dialysate production make it an enterprise solution for all settings – from the ICU to the home – and eliminates the need for separate water purification. Its easy-to-learn interface enables virtually anyone to be trained to administer dialysis. In the clinic setting, Tablo can automate many processes for both patients and staff, eliminate the need for costly infrastructure, lower staff costs by maximizing productivity, and help your clinic more efficiently and effectively manage patients. Tablo is designed to facilitate home program growth by allowing clinics to easily on-board and retain home patients through a quick and simple training and setup process. Tablo’s unique self-care level empowers patients to participate in their care in-center and at home. Tablo Patients also stick to their routines – we’ve seen over 96% compliance to treatment schedules and our trial saw no patient drop out of the home arm.1 What specific treatment modalities is Tablo capable of delivering? I’m interested in implementing a home program with Tablo. Where do I start? What kind of training is involved? How long does it take? How much does Tablo cost? What kind of support does Outset provide? References 1 Safety and Efficacy of the Tablo Hemodialysis System for In-Center and In-Home Hemodialysis (T. Plumb et al, “HDI”, 2020; 24:22-28) 2 Early Experience with a Novel Hemodialysis System used for PIRRT Demonstrates Clinical Management at Lower Cost than CRRT & IHD (S. Demirjianet al., CRRT, 2019) 3 Experience with a Novel Hemodialysis System: UserSatisfaction and Clearance (M. Rahman et al., ASN, 2019) 4 Results of human factors testing in a novel Hemodialysis system designed for ease of patient use. (Wilcox, S. B., Carver, M., Yau, M., Sneeringer, P., Prichard, S., Alvarez, L., & Chertow, G. M., 2016) DOC-0006337 rev. 2 Outset Medical 3052 Orchard Drive San Jose, CA 95134 Contact Us Privacy Policy © 2021 Outset Medical, Inc. All rights reserved. “Tablo” is a trademark of our company. Technology is at the core of what we do, so it should be no surprise that we use analytics and cookies to provide you with a great experience on our site and deliver targeted advertising. You can read more about our cookies in our Privacy Policy, including your rights to adjust browser cookie settings or use advertising industry cookie opt-outs. Close